RegenLab, Regenerative Medicine Devices and PRP/HA Platforms, Files for Nasdaq IPO

RegenLab filed an S—1 on September 25, 2026 for an underwritten initial public offering. The company plans to list on the Nasdaq under the ticker “RGNA,” with StoneX Financial Inc. as sole book—running manager. The filing does not yet specify a price range or share count; proceeds are earmarked for…